4.2 Article

Diversity of the clinical presentation of the MMR gene biallelic mutations

Journal

FAMILIAL CANCER
Volume 13, Issue 1, Pages 131-135

Publisher

SPRINGER
DOI: 10.1007/s10689-013-9676-1

Keywords

MMR; Mutation; Tumour

Funding

  1. INCa
  2. French National Cancer Institute

Ask authors/readers for more resources

Constitutional mismatch repair-deficiency, due to biallelic mutations of MMR genes, results in a tumour spectrum characterized by leukaemias, lymphomas, brain tumours and adenocarcinomas of the gastro-intestinal tract, occurring mostly in childhood. We report here two families illustrating the phenotypic diversity associated with biallelic MMR mutations. In the first family, two siblings developed six malignancies including glioblastoma, lymphoblastic T cell lymphoma, rectal and small bowel adenocarcinoma with onset as early as 6 years of age. We showed that this dramatic clinical presentation was due to the presence of two complex genomic PMS2 deletions in each patient predicted to result into complete PMS2 inactivation. In the second family, the index case presented with an early form of Lynch syndrome with colorectal adenocarcinomas at ages 17 and 20 years, and urinary tract tumours at the age of 25 years. We identified in this patient two MSH6 mutations corresponding to a frameshift deletion and an in frame deletion. The latter was not predicted to result into complete inactivation of MSH6. These reports show that the clinical expression of biallelic MMR mutations depends on the biological impact of the second MMR mutation and that, in clinical practice, the presence of a second MMR mutation located in trans should also be considered in patients suspected to present a Lynch syndrome with an unusual early-onset of tumours.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Blood functional assay for rapid clinical interpretation of germline TP53 variants

Sabine Raad, Marion Rolain, Sophie Coutant, Celine Derambure, Raphael Lanos, Francoise Charbonnier, Jacqueline Bou, Emilie Bouvignies, Gwendoline Lienard, Stephanie Vasseur, Michael Farrell, Olivier Ingster, Stephanie Baert Desurmont, Edwige Kasper, Gaelle Bougeard, Thierry Frebourg, Isabelle Tournier

Summary: The study developed a functional assay directly performed on patients' blood, which can be a useful tool for the rapid clinical classification of germline TP53 variants and detection of non-coding functional variants.

JOURNAL OF MEDICAL GENETICS (2021)

Article Critical Care Medicine

Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre-Regis Burgel, Isabelle Durieu, Raphael Chiron, Sophie Ramel, Isabelle Danner-Boucher, Anne Prevotat, Dominique Grenet, Christophe Marguet, Martine Reynaud-Gaubert, Julie Macey, Laurent Mely, Annlyse Fenton, Sebastien Quetant, Lydie Lemonnier, Jean-Louis Paillasseur, Jennifer Da Silva, Clemence Martin

Summary: An observational study in France found that the use of elexacaftor-tezacaftor-ivacaftor in CF patients led to significant improvements in lung function and weight within a short period of time, with most patients no longer requiring long-term oxygen, noninvasive ventilation, and/or enteral tube feeding. Compared to the previous two years, there was a twofold decrease in the number of lung transplantations in CF patients in 2020.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Review Genetics & Heredity

A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement

Sofia Douzgou, Myfanwy Rawson, Eulalia Baselga, Moise Danielpour, Laurence Faivre, Alon Kashanian, Kim M. Keppler-Noreuil, Paul Kuentz, Grazia M. S. Mancini, Marie-Cecile Maniere, Victor Martinez-Glez, Victoria E. Parker, Robert K. Semple, Siddharth Srivastava, Pierre Vabres, Marie-Claire Y. De Wit, John M. Graham, Jill Clayton-Smith, Ghayda M. Mirzaa, Leslie G. Biesecker

Summary: Growth promoting variants in PIK3CA can cause a range of developmental disorders, grouped as PIK3CA-Related Overgrowth Spectrum disorders (PROS). Managing these conditions presents challenges due to clinical heterogeneity and lack of medical expertise in affected families. A consensus on management guidelines is needed to address these issues effectively.

CLINICAL GENETICS (2022)

Letter Dermatology

Expanding the clinical spectrum of mosaic BRAF skin phenotypes

A. Sorlin, V. Carmignac, J. Amiel, O. Boccara, S. Fraitag, A. Maruani, M. Theiler, L. Weibel, Y. Duffourd, C. Philippe, C. Thauvin-Robinet, L. Faivre, J. -B. Riviere, P. Vabres, P. Kuentz

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Skin conditions among 20th century politicians and world leaders

N. Kluger, A. Perciaccante, P. Charlier, P. Vabres

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Genetics & Heredity

Health care transition for patients with vascular malformations: a French multicenter cross-sectional study

Camille Vermersch, Olivia Boccara, Christine Chiaverini, Juliette Mazereeuw-Hautier, Nina Sigg, Stephanie Mallet, Pierre Vabres, Denis Herbreteau, Anne Le Touze, Annabel Maruani, Sophie Leducq

Summary: Health care transition in rare chronic skin diseases presents challenges, with a high rate of lost to follow-up. Early management may be associated with lower lost to follow-up rates. Patients reported overall satisfaction with care but noted a lack of psychological support. Further studies are needed to explore risk factors for unsuccessful health care transition and its implications.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Acoustics

Clinical and molecular data in cases of prenatal localized overgrowth disorder: major implication of genetic variants in PI3K-AKT-mTOR signaling pathway

N. Bourgon, V Carmignac, A. Sorlin, Y. Duffourd, C. Philippe, C. Thauvin-Robinet, L. Guibaud, L. Faivre, P. Vabres, P. Kuentz

Summary: This study retrospectively analyzed data from a French multicenter cohort of fetuses with prenatal diagnosis of congenital abnormality. The findings suggest that isolated megalencephaly or hemimegalencephaly may be associated with genetic variants in the PI3K-AKT-mTOR signaling pathway. Limb overgrowth with lymphatic malformations or isolated hemimegalencephaly is likely to be associated with PIK3CA variants.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)

Article Pediatrics

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium

Imke Anise Maartje Ditters, Hidde Harmen Huidekoper, Michelle Elisabeth Kruijshaar, Dimitris Rizopoulos, Andreas Hahn, Tiziana Enrico Mongini, Francois Labarthe, Marine Tardieu, Brigitte Chabrol, Anais Brassier, Rossella Parini, Giancarlo Parenti, Nadine Anna Maria Elisabeth van der Beek, Ans Tjitske van der Ploeg, Johanna Maria Pieternel van den Hout

Summary: This study assessed the effect of enzyme replacement therapy (ERT) with alglucosidase alfa on survival and walking ability in patients with classic infantile Pompe disease. The results showed that a high ERT dosage of 40 mg/kg per week significantly improved survival compared to the standard recommended dosage of 20 mg/kg every other week. These findings suggest a need for reconsideration of the currently registered dosage.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Letter Dermatology

Quality of life of children with capillary malformations of the lower limbs: Evolution and associated factors. Data from the French national paediatric cohort, CONAPE

J. Robert, A. Marchand, J. Mazereeuw-Hautier, O. Boccara, L. Martin, C. Chiaverini, N. Beneton, P. Vabres, X. Balguerie, P. Plantin, D. Bessis, S. Barbarot, A. Dadban, C. Droitcourt, M. Samimi, B. Morel, A. Caille, A. Maruani, S. Leducq

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2022)

Letter Dermatology

Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus

Annabel Maruani, Anne-Guillemette Moineau, Olivia Boccara, Juliette Mazereeuw-Hautier, Sophie Leducq, Didier Bessis, Laurent Guibaud, Pierre Vabres, Stephanie Mallet, Sebastien Barbarot, Christine Chiaverini, Catherine Droitcourt, Anne-Claire Bursztejn, Celine Lengelle, Jean-Baptiste Woillard, Denis Herbreteau, Anne Le Touze, Aurelien Binet, Baptiste Morel, Helene Bourgoin, Valerie Gissot, Bruno Giraudeau, Yves Gruel, Elsa Tavernier, Jerome Rollin

Summary: Slow-flow vascular malformations, especially those with venous components, can cause localized intravascular coagulopathy, resulting in pain and reduced quality of life. Previous studies have shown the effectiveness of mTOR inhibitors, particularly sirolimus, on slow-flow VMs, but the effect on coagulation has been poorly studied, especially in children. Our study provides novel evidence that sirolimus improves coagulation abnormalities in venous malformations, although predictive biomarkers of response to sirolimus were not clearly identified, making this the first attempt to highlight potential predictive markers.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Editorial Material Dermatology

Infantile haemangioma in a 17th-century painting

Nicolas Kluger, Pierre Vabres

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Oncology

Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer

Corentin Levacher, Mathieu Viennot, Aurelie Drouet, Ludivine Beaussire, Sophie Coutant, Jean-Christophe Thery, Stephanie Baert-Desurmont, Marick Lae, Philippe Ruminy, Claude Houdayer

Summary: This study investigates the imbalance in circular RNA/messenger RNA ratio in breast cancer and reveals new mechanisms and associated biomarkers. The findings have crucial implications for early detection and prognosis of breast cancer.

CANCERS (2023)

Meeting Abstract Biochemistry & Molecular Biology

Creation of a joint consortium to treat Kosaki syndrome

Maxime Luu, Alison Foster, Cristina Aguirre Rodriguez, Hanna Westergren, Unai Hernandez Dorronsor, Itziar Martinez Soroa, Derek Lim, Sarah Thompson, Ann Nordgren, Sara Bluefeather, Elise Schaefer, Marc Bardou, Pierre Vabres, Jean-Emmanuel Kurtz, Laurence Faivre

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Meeting Abstract Biochemistry & Molecular Biology

Low risk of embryonal cancer in PIK3CA-Related Overgrowth Spectrum: impact on screening recommendations

Laurence Faivre, Jean-Charles Crepin, Manon Reda, Sophie Nambot, Virginie Carmignac, Caroline Abadie, Audrey Putoux, Juliette Mazereeuw-Hautier, Aude Maza, Maxime Luu, Yannis Duffourd, Christophe Philippe, Christel Thauvin-Robinet, Martin Chevarin, Claire Abasq-Thomas, Jeanne Amiel, Stephanie Arpin, Genevieve Baujat, Didier Bessis, Emmanuelle Bourrat, Odile Boute, Anne-Claire Bursztejn, Nicolas Chassaing, Christine Coubes, Patrick Edery, Salima El Chehadeh, Alice Goldenberg, Smail Hadj-Rabia, Damien Haye, Bertrand Isidor, Marie-Line Jacquemont, Didier Lacombe, Bruno Leheup, Ludovic Martin, Anabel Maruani, Fanny Morice-Picard, Florence Petit, Alice Phan, Lucille Pinson, Eve Puzenat, Massimiliano Rossi, Renaud Touraine, Clemence Vanlerberghe, Marie Vincent, Catherine Vincent-Delorme, Sandra Whalen, Marjolaine Willems, Tristan Mirault, Paul Kuentz, Pierre Vabres

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Meeting Abstract Biochemistry & Molecular Biology

Digging exome sequencing data: An example of a homozygous mobile element insertion detected in a rare disease cohort

Philippine Garret, Martin Chevarin, Antonio Vitobello, Simon Verdez, Cyril Fournier, Alain Verloes, Emilie Tisserant, Pierre Vabres, Orlane Prevel, Christophe Philippe, Anne-Sophie Denomme-Pichon, Ange-Line Bruel, Frederic Tran Mauthem, Hana Safraou, Aicha Boughalem, Jean-Marc Costa, Detlef Trost, Laurence Faivre, Christel Thauvin-Robinet, Yannis Duffourd

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

No Data Available